Scandion Oncology
Overcoming cancer drug resistance

Navbar

Research & Development
News & Press
- Press releases
Investors

Skip to content

INVESTOR

Analyst Coverage

Redeye

Christian Binder
christian.binder@redeye.se

Redeye’s corporate page on Scandion Oncology can be found here

Frontpage
Investors
Analyst Coverage

About us

Research & Development

Research & Development
Pipeline
Clinical Development
Science

News & Press

Press releases
Other news
Image library items
Video library items

Investors

Investors
Share information
Financial Reports
Presentations
Analyst Coverage
Prospectuses
Corporate governance
Events

Scandion Oncology - The Cancer Drug Resistance Company

Our vision is to overcome cancer drug resistance in order to improve lives for cancer patients and their families

© Copyright 2022 - Scandion Oncology A/S | We use cookies to improve our services | Disclaimer: Market data could be delayed. Delivered by Cision.